Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
Phase 1
Active, not recruiting
- Conditions
- AMLAcute Myeloid Leukemia
- Interventions
- Drug: Palcociclib
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Sudipto Mukherjee
- Target Recruit Count
- 36
- Registration Number
- NCT03844997
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath